Versions Compared

Old Version 5

changes.mady.by.user ZHATKIN Yurii

Saved on

compared with

New Version Current

changes.mady.by.user MONTARD Laurence

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Info
titleYou are here:
Breadcrumb

Answer:

No. The CEP is an official procedure implemented by EU Directive; it is one possible option for applying for marketing authorisation in Europe.

optional and not a mandatory requirement in Europe for marketing substances. Nevertheless, it is the preferred option to demonstrate for demonstrating that a substance used in the preparation of medicinal products comply complies with the European Pharmacopoeia specifications according to the the Note for Guidance on summary requirements for active substances in the quality part of the dossier (CPMP /QWP/297/97 Rev 1 corr; EMEA/CVMP/1069/02).

It is also the preferred option to demonstrate for demonstrating compliance with the requirements concerning TSE risk (general chapter 5.2.8 of Ph. Eur. = EMEA  EMA NfG 410/01 ; on minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products).